Mark Applebaum to Prospective Studies
This is a "connection" page, showing publications Mark Applebaum has written about Prospective Studies.
Connection Strength
0.056
-
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 08; 28(8):1581-1589.
Score: 0.028
-
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease. Cancer. 2022 08 01; 128(15):2967-2977.
Score: 0.028